Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 173
interventional 160
Observational 11
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 38
Drug|Other 17
Biological|Drug|Procedure|Radiation 15
Biological|Drug|Procedure 14
Biological 8
Drug|Procedure|Radiation 7
Biological|Drug 6
Drug|Other|Procedure|Radiation 6
Drug|Procedure 5
Biological|Drug|Other|Procedure|Radiation 4
Biological|Drug|Other 3
Biological|Drug|Radiation 3
Drug|Other|Procedure 3
Drug|placebo 3
Drug|Radiation 3
Biological|Drug|Genetic|Other|Procedure 2
Biological|Drug|Other|Procedure 2
Biological|Other 2
Biological|Procedure 2
Dietary Supplement 2
Dietary Supplement|Drug 2
Other 2
Other|Procedure 2
Procedure 2
Behavioral|Dietary Supplement|Other|Procedure 1
Biological|Device|Drug|Procedure|Radiation 1
Device 1
Drug|Genetic|Other|Procedure 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Other|placebo|Procedure 1
Drug|placebo|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 135
United States|Italy 4
NA 3
United States|Germany|Italy 3
Korea, Republic of 2
United Kingdom 2
United States|Canada 2
Canada|United States|Australia|Netherlands|New Zealand|Puerto Rico|Switzerland 1
France 1
United States|Australia|Canada 1
United States|Australia|Canada|Puerto Rico 1
United States|Canada|New Zealand 1
United States|Canada|Puerto Rico 1
United States|Denmark|Germany 1
United States|France|United Kingdom 1
United States|Germany 1

Sites per Study

Site_count Study_Count
1 111
2 13
3 2
4 4
5 5
6 3
7 2
8 1
10 2
11 4
14 1
21 1
23 1
24 1
25 1
35 1
43 1
45 1
68 1
85 1
165 1
237 1
326 1

Phase

Phase Study_Count
Phase 2 73
Phase 1 40
Phase 1/Phase 2 16
N/A 15
Phase 3 15
Phase 2/Phase 3 1

Number of Arms

Number_of_Arms Count_of_Studies
1 58
2 29
3 6
6 3
9 1
NA 63

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3
Min. 5.00000 17.0 21.00000 3.00000 362 25.00
1st Qu. 11.50000 27.5 31.50000 24.75000 362 114.50
Median 32.00000 42.0 34.00000 46.50000 362 217.00
Mean 62.85714 42.0 65.63636 66.83333 362 440.50
3rd Qu. 76.25000 55.5 43.50000 70.50000 362 504.25
Max. 282.00000 70.0 271.00000 390.00000 362 2000.00

Trial Group Type

group_type Group_Count
Experimental 130
NA 63
Active Comparator 18
Other 5
Placebo Comparator 4
No Intervention 3
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 69
NA 53
Parallel Assignment 35
Crossover Assignment 1
Factorial Assignment 1
Sequential Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 123
Supportive Care 31
Prevention 2
NA 2
Diagnostic 1
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
United States 11

Sites per Study

Site_count Study_Count
1 4
2 3
3 1
7 1
280 1
292 1

Enrollment Metrics

Measure Observational
Min 36.000
1st Qu 160.500
Median 459.000
Mean 2243.818
3rd Qu 2147.000
Max 15000.000

Observation Model

observational_model Study_Count
NA 4
Cohort 3
Case-Control 1
Case-Only 1
Case Control 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 7
NA 4

Registries

Studies by Country

Country Study_Count
Canada 1
Italy 1

Sites per Study

Site_count Study_Count
1 1
19 1

Enrollment Metrics

Measure Registries
Min 1000
1st Qu 2000
Median 3000
Mean 3000
3rd Qu 4000
Max 5000

Registry Model

observational_model Study_Count
Case-Only 1
Cohort 1

Time Perspective

time_perspective Study_Count
Other 1
Prospective 1

Follow-up

target_duration Study_Count
10 Years 1
2 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03289910 Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia https://ClinicalTrials.gov/show/NCT03289910 Recruiting National Cancer Institute (NCI) 2021-06-01
NCT03246906 Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation https://ClinicalTrials.gov/show/NCT03246906 Recruiting Fred Hutchinson Cancer Research Center 2022-08-15
NCT02861417 Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT02861417 Recruiting M.D. Anderson Cancer Center 2021-08-31
NCT02727803 Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma https://ClinicalTrials.gov/show/NCT02727803 Recruiting M.D. Anderson Cancer Center 2020-05-19
NCT02666950 WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02666950 Completed Mayo Clinic 2018-09-25
NCT02257138 Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02257138 Active, not recruiting M.D. Anderson Cancer Center 2021-02-28
NCT02493530 TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea https://ClinicalTrials.gov/show/NCT02493530 Active, not recruiting Vanderbilt-Ingram Cancer Center 2020-12-31
NCT02210858 Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT02210858 Completed National Cancer Institute (NCI) 2004-11-12
NCT02158858 A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis https://ClinicalTrials.gov/show/NCT02158858 Recruiting Constellation Pharmaceuticals 2021-08-31
NCT02129101 Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies https://ClinicalTrials.gov/show/NCT02129101 Completed Mayo Clinic 2016-12-31
NCT01305200 Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01305200 Completed Children’s Oncology Group 2015-06-30
NCT01273766 Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01273766 Completed Wake Forest University Health Sciences 2012-03-31
NCT01894477 Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01894477 Active, not recruiting Fred Hutchinson Cancer Research Center 2017-01-09
NCT01872819 Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay https://ClinicalTrials.gov/show/NCT01872819 Completed University of Washington 2014-11-30
NCT01831232 Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT01831232 Completed Fred Hutchinson Cancer Research Center 2015-02-28
NCT01789255 Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01789255 Completed National Cancer Institute (NCI) 2014-03-31
NCT01787487 Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm https://ClinicalTrials.gov/show/NCT01787487 Recruiting M.D. Anderson Cancer Center 2020-07-26
NCT01712308 Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia https://ClinicalTrials.gov/show/NCT01712308 Recruiting M.D. Anderson Cancer Center 2020-02-28
NCT01529827 Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01529827 Completed Roswell Park Cancer Institute 2015-05-28
NCT01527045 Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01527045 Completed Fred Hutchinson Cancer Research Center 2018-10-31
NCT01484015 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia https://ClinicalTrials.gov/show/NCT01484015 Completed Wake Forest University Health Sciences 2012-06-30
NCT01384513 A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT01384513 Recruiting Thomas Jefferson University 2020-12-31
NCT03878524 Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial https://ClinicalTrials.gov/show/NCT03878524 Recruiting OHSU Knight Cancer Institute 2022-02-27
NCT04282187 Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms https://ClinicalTrials.gov/show/NCT04282187 Recruiting University of Washington 2024-11-11
NCT04022785 PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT04022785 Recruiting M.D. Anderson Cancer Center 2022-12-31
NCT03862157 Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03862157 Recruiting M.D. Anderson Cancer Center 2024-01-01
NCT03630991 Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy https://ClinicalTrials.gov/show/NCT03630991 Active, not recruiting M.D. Anderson Cancer Center 2020-12-31
NCT03613532 Venetoclax Added to Fludarabine + Busulfan Prior to Transplant for AML, MDS, and MDS/MPN https://ClinicalTrials.gov/show/NCT03613532 Recruiting Dana-Farber Cancer Institute 2020-10-01
NCT03560752 CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Blood Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03560752 Recruiting City of Hope Medical Center 2021-03-18
NCT03519984 EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia https://ClinicalTrials.gov/show/NCT03519984 Recruiting University of Southern California 2020-05-09
NCT03434730 Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation https://ClinicalTrials.gov/show/NCT03434730 Recruiting Memorial Sloan Kettering Cancer Center 2021-02-07
NCT01233921 Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT01233921 Completed Fred Hutchinson Cancer Research Center 2012-07-31
NCT01164163 INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease https://ClinicalTrials.gov/show/NCT01164163 Completed Children’s Oncology Group 2014-10-31
NCT01093586 Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01093586 Completed Case Comprehensive Cancer Center 2015-12-31
NCT01056614 Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies https://ClinicalTrials.gov/show/NCT01056614 Completed Fred Hutchinson Cancer Research Center 2005-08-31
NCT00988715 Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00988715 Completed Fred Hutchinson Cancer Research Center 2015-01-31
NCT00951626 A Standardized Nursing Intervention Protocol for HCT Patients https://ClinicalTrials.gov/show/NCT00951626 Completed City of Hope Medical Center 2011-09-30
NCT00935090 3’-Deoxy-3’-[18F] Fluorothymidine PET Imaging in Patients With Cancer https://ClinicalTrials.gov/show/NCT00935090 Recruiting Barbara Ann Karmanos Cancer Institute 2021-04-30
NCT00908167 Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00908167 Completed St. Jude Children’s Research Hospital 2015-06-30
NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy https://ClinicalTrials.gov/show/NCT00890747 Completed National Cancer Institute (NCI) 2011-05-31
NCT00856388 Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders https://ClinicalTrials.gov/show/NCT00856388 Completed Roswell Park Cancer Institute 2012-08-09
NCT00823524 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00823524 Completed Asan Medical Center 2013-02-28
NCT00806767 Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer https://ClinicalTrials.gov/show/NCT00806767 Completed National Cancer Institute (NCI) 2011-05-31
NCT00787761 Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer https://ClinicalTrials.gov/show/NCT00787761 Completed Northside Hospital, Inc. 2010-07-31
NCT00782145 A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families https://ClinicalTrials.gov/show/NCT00782145 Completed Tufts Medical Center 2011-06-30
NCT00755040 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder https://ClinicalTrials.gov/show/NCT00755040 Completed Vanderbilt-Ingram Cancer Center 2014-12-31
NCT00750009 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial https://ClinicalTrials.gov/show/NCT00750009 Completed Case Comprehensive Cancer Center 2012-12-31
NCT00719563 American Ginseng in Treating Patients With Fatigue Caused by Cancer https://ClinicalTrials.gov/show/NCT00719563 Completed Alliance for Clinical Trials in Oncology 2011-08-31
NCT00716911 Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00716911 Completed City of Hope Medical Center 2007-07-31
NCT00691015 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00691015 Completed Barbara Ann Karmanos Cancer Institute 2014-04-30
NCT00666211 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain https://ClinicalTrials.gov/show/NCT00666211 Completed Vanderbilt-Ingram Cancer Center 2010-01-31
NCT00627666 Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer https://ClinicalTrials.gov/show/NCT00627666 Completed National Cancer Institute (NCI) 2010-06-30
NCT00624936 Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00624936 Completed Ohio State University Comprehensive Cancer Center 2009-12-31
NCT00611351 Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00611351 Completed University of Nebraska 2008-02-29
NCT00589563 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer https://ClinicalTrials.gov/show/NCT00589563 Completed City of Hope Medical Center 2012-02-29
NCT00588809 Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00588809 Completed National Cancer Institute (NCI) 2012-04-30
NCT00544115 Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders https://ClinicalTrials.gov/show/NCT00544115 Active, not recruiting City of Hope Medical Center 2019-11-30
NCT00530218 Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00530218 Completed City of Hope Medical Center 2010-02-28
NCT00516503 Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer https://ClinicalTrials.gov/show/NCT00516503 Completed Alliance for Clinical Trials in Oncology 2009-04-30
NCT00513474 Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00513474 Completed Massachusetts General Hospital 2013-02-12
NCT00489203 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00489203 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00462605 MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00462605 Completed National Cancer Institute (NCI) 2011-03-31
NCT00425477 Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00425477 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2016-09-30
NCT00410657 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00410657 Completed Fred Hutchinson Cancer Research Center 2006-11-30
NCT00408681 Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00408681 Completed Fred Hutchinson Cancer Research Center 2010-11-30
NCT00799461 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications https://ClinicalTrials.gov/show/NCT00799461 Completed Fred Hutchinson Cancer Research Center 2011-11-30
NCT00376922 Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases https://ClinicalTrials.gov/show/NCT00376922 Completed Wake Forest University Health Sciences 2007-05-31
NCT00357708 Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases https://ClinicalTrials.gov/show/NCT00357708 Completed National Cancer Institute (NCI) 2009-10-31
NCT00357305 Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00357305 Completed National Cancer Institute (NCI) 2011-11-30
NCT00351975 Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases https://ClinicalTrials.gov/show/NCT00351975 Completed National Cancer Institute (NCI) 2013-03-31
NCT00346359 Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer https://ClinicalTrials.gov/show/NCT00346359 Completed Fred Hutchinson Cancer Research Center NA
NCT00331513 Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00331513 Completed National Cancer Institute (NCI) 2010-01-31
NCT00322101 Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia https://ClinicalTrials.gov/show/NCT00322101 Completed Fred Hutchinson Cancer Research Center 2012-04-30
NCT00301938 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00301938 Completed National Cancer Institute (NCI) 2012-05-31
NCT00293410 Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00293410 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2010-04-30
NCT00293384 Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00293384 Completed Barbara Ann Karmanos Cancer Institute 2009-06-30
NCT00274820 Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT00274820 Completed Case Comprehensive Cancer Center 2007-09-30
NCT00265837 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00265837 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2007-08-31
NCT00255710 Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00255710 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00245037 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00245037 Completed OHSU Knight Cancer Institute 2015-08-31
NCT00217386 Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00217386 Completed Fred Hutchinson Cancer Research Center 2007-12-31
NCT00118352 Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00118352 Completed Fred Hutchinson Cancer Research Center 2010-07-31
NCT00114257 Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00114257 Completed National Cancer Institute (NCI) 2006-09-30
NCT00112593 Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer https://ClinicalTrials.gov/show/NCT00112593 Completed Fred Hutchinson Cancer Research Center 2014-11-30
NCT00109993 Campath-1H + FK506 and Methylprednisolone for GVHD https://ClinicalTrials.gov/show/NCT00109993 Completed Case Comprehensive Cancer Center 2006-06-30
NCT00105001 Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00105001 Completed Fred Hutchinson Cancer Research Center 2011-05-31
NCT00104975 Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer https://ClinicalTrials.gov/show/NCT00104975 Completed Yale University 2008-05-31
NCT00098683 Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00098683 Completed Children’s Oncology Group 2007-10-31
NCT00096161 Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00096161 Completed Fred Hutchinson Cancer Research Center 2015-02-28
NCT00096096 Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00096096 Completed Fred Hutchinson Cancer Research Center 2006-05-31
NCT00093366 Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00093366 Completed Fred Hutchinson Cancer Research Center NA
NCT00089037 Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00089037 Completed Fred Hutchinson Cancer Research Center 2005-04-30
NCT00006251 Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer https://ClinicalTrials.gov/show/NCT00006251 Completed Fred Hutchinson Cancer Research Center 2005-09-30
NCT00082654 Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients https://ClinicalTrials.gov/show/NCT00082654 Completed Fred Hutchinson Cancer Research Center 2004-10-31
NCT00083187 VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia https://ClinicalTrials.gov/show/NCT00083187 Completed National Cancer Institute (NCI) 2007-01-31
NCT00080925 T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00080925 Completed National Institutes of Health Clinical Center (CC) NA
NCT00078858 Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00078858 Completed Fred Hutchinson Cancer Research Center 2006-01-31
NCT00077558 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00077558 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00075816 Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) https://ClinicalTrials.gov/show/NCT00075816 Completed Medical College of Wisconsin 2013-04-30
NCT00075478 Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00075478 Completed Fred Hutchinson Cancer Research Center 2014-02-28
NCT00072475 Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00072475 Completed Alliance for Clinical Trials in Oncology 2008-11-30
NCT00068523 Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00068523 Completed Case Comprehensive Cancer Center 2004-03-31
NCT00068276 Cholecalciferol in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00068276 Completed Wake Forest University Health Sciences 2005-06-30
NCT00066599 Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy https://ClinicalTrials.gov/show/NCT00066599 Completed National Cancer Institute (NCI) NA
NCT00066248 Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment https://ClinicalTrials.gov/show/NCT00066248 Completed University of South Florida 2007-08-31
NCT00064311 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00064311 Completed National Institutes of Health Clinical Center (CC) NA
NCT00003913 Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease https://ClinicalTrials.gov/show/NCT00003913 Completed Fred Hutchinson Cancer Research Center 2005-08-31
NCT00064090 3-AP and Cytarabine in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00064090 Completed National Cancer Institute (NCI) 2004-09-30
NCT00062140 Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00062140 Completed Fred Hutchinson Cancer Research Center NA
NCT00006225 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer https://ClinicalTrials.gov/show/NCT00006225 Completed Northwestern University 2004-01-31
NCT00055653 Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders https://ClinicalTrials.gov/show/NCT00055653 Completed Roswell Park Cancer Institute 2003-09-30
NCT00054340 Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT00054340 Completed Fred Hutchinson Cancer Research Center NA
NCT00054327 Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00054327 Completed Case Comprehensive Cancer Center 2011-09-30
NCT00054236 Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia https://ClinicalTrials.gov/show/NCT00054236 Completed Case Comprehensive Cancer Center 2011-03-31
NCT00053989 NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders https://ClinicalTrials.gov/show/NCT00053989 Completed Roswell Park Cancer Institute 2018-07-19
NCT00053287 Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS https://ClinicalTrials.gov/show/NCT00053287 Completed Case Comprehensive Cancer Center 2007-01-31
NCT00053157 Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia https://ClinicalTrials.gov/show/NCT00053157 Completed Roswell Park Cancer Institute 2004-08-31
NCT00053001 Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00053001 Completed National Cancer Institute (NCI) NA
NCT00052832 Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia https://ClinicalTrials.gov/show/NCT00052832 Completed University of Wisconsin, Madison 2005-07-31
NCT00049686 VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00049686 Completed National Cancer Institute (NCI) NA
NCT00049634 Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT00049634 Completed Fred Hutchinson Cancer Research Center 2007-02-28
NCT00045305 Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00045305 Completed Eastern Cooperative Oncology Group 2014-02-28
NCT00044954 Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00044954 Completed University of Texas Southwestern Medical Center 2006-11-30
NCT00042822 FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin’s Lymphoma https://ClinicalTrials.gov/show/NCT00042822 Completed National Cancer Institute (NCI) 2005-03-31
NCT00040846 Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies https://ClinicalTrials.gov/show/NCT00040846 Completed Fred Hutchinson Cancer Research Center 2009-12-31
NCT00036790 Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT00036790 Completed University of Wisconsin, Madison 2005-10-31
NCT00030550 Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00030550 Completed Roswell Park Cancer Institute 2003-06-30
NCT00028730 Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00028730 Completed Memorial Sloan Kettering Cancer Center 2006-07-31
NCT00027560 Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00027560 Completed Memorial Sloan Kettering Cancer Center 2009-04-30
NCT00025415 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction https://ClinicalTrials.gov/show/NCT00025415 Completed National Cancer Institute (NCI) 2005-01-31
NCT00022048 Bevacizumab in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00022048 Completed National Cancer Institute (NCI) NA
NCT00019656 Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer https://ClinicalTrials.gov/show/NCT00019656 Completed National Cancer Institute (NCI) NA
NCT00015925 MS-275 in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00015925 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00014495 Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer https://ClinicalTrials.gov/show/NCT00014495 Completed Memorial Sloan Kettering Cancer Center 2009-12-31
NCT00014469 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer https://ClinicalTrials.gov/show/NCT00014469 Completed Memorial Sloan Kettering Cancer Center 2007-05-31
NCT00795769 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00795769 Completed Fred Hutchinson Cancer Research Center 2009-06-09
NCT00014235 Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies https://ClinicalTrials.gov/show/NCT00014235 Completed Fred Hutchinson Cancer Research Center 2005-02-28
NCT00006379 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA https://ClinicalTrials.gov/show/NCT00006379 Completed Case Comprehensive Cancer Center 2004-01-31
NCT00006239 Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00006239 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2005-02-28
NCT00006042 Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00006042 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00006040 Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia https://ClinicalTrials.gov/show/NCT00006040 Completed Memorial Sloan Kettering Cancer Center 2003-11-30
NCT00005863 Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00005863 Completed National Cancer Institute (NCI) NA
NCT00005823 Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00005823 Completed National Cancer Institute (NCI) NA
NCT00005797 Bone Marrow Transplant in Treating Patients With Hematologic Cancers https://ClinicalTrials.gov/show/NCT00005797 Completed H. Lee Moffitt Cancer Center and Research Institute 2007-07-31
NCT00005622 Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders https://ClinicalTrials.gov/show/NCT00005622 Completed H. Lee Moffitt Cancer Center and Research Institute 2005-09-30
NCT00004899 Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00004899 Completed Northwestern University 2004-08-31
NCT00004896 Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00004896 Completed Northwestern University 2004-08-31
NCT00004871 Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00004871 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00004245 Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT00004245 Completed Memorial Sloan Kettering Cancer Center 2004-09-30
NCT00003961 Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00003961 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2007-12-31
NCT00003816 Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003816 Completed Roswell Park Cancer Institute 2019-07-12
NCT00003593 Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00003593 Completed Children’s Oncology Group 2007-03-31
NCT00003336 Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions https://ClinicalTrials.gov/show/NCT00003336 Completed Case Comprehensive Cancer Center 2005-12-31
NCT00003335 Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003335 Completed Case Comprehensive Cancer Center 2007-11-30
NCT00003243 Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003243 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NA
NCT00003116 High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00003116 Completed Case Comprehensive Cancer Center 2006-03-31
NCT00002809 Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00002809 Completed Temple University 2003-12-31
NCT00002792 Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders https://ClinicalTrials.gov/show/NCT00002792 Completed Fred Hutchinson Cancer Research Center 2003-04-30
NCT00002746 Interleukin-2 in Treating Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00002746 Completed University of Washington 2004-04-30
NCT00002718 T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia https://ClinicalTrials.gov/show/NCT00002718 Completed Memorial Sloan Kettering Cancer Center 2004-01-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02269592 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome https://ClinicalTrials.gov/show/NCT02269592 Recruiting Dana-Farber Cancer Institute 2024-12-31
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01137825 Registry of Older Patients With Cancer https://ClinicalTrials.gov/show/NCT01137825 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2030-06-30
NCT01137643 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT01137643 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2040-07-31
NCT00996047 S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers https://ClinicalTrials.gov/show/NCT00996047 Completed Southwest Oncology Group 2012-01-31
NCT00993694 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone https://ClinicalTrials.gov/show/NCT00993694 Completed Vanderbilt University Medical Center 2009-12-31
NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00964821 Completed City of Hope Medical Center 2013-05-31
NCT00919425 S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00919425 Completed Southwest Oncology Group 2012-01-31
NCT00900406 Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00900406 Completed Vanderbilt-Ingram Cancer Center 2010-03-31
NCT00281814 Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00281814 Completed The Cleveland Clinic 2008-12-31
NCT00281801 Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation https://ClinicalTrials.gov/show/NCT00281801 Completed Case Comprehensive Cancer Center 2008-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02808858 Italian Network MDS Registry https://ClinicalTrials.gov/show/NCT02808858 Recruiting Fondazione Italiana Sindromi Mielodisplastiche Onlus 2016-06-30
NCT02760238 Myeloproliferative Neoplasms (MPNs) Patient Registry https://ClinicalTrials.gov/show/NCT02760238 Recruiting University Health Network, Toronto 2025-10-31